3 news items
Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
PTPI
21 May 24
of subject matter experts, which include former FDA officials, will be instrumental in helping to ensure our development program is pursued with the same
Petros Pharmaceuticals Receives Response From FDA Following Recent Demonstration Of Technology Component In Pursuit Of OTC Status For STENDRA
PTPI
16 Apr 24
, and we will incorporate it as we continue to move forward. We are grateful for the input from our internal advisory committee and subject matter experts
Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
PTPI
16 Apr 24
committee and subject matter experts and are confident that the incorporation of assistive technology has the potential to improve our process, resulting
- Prev
- 1
- Next